Thomas Werner
Member of Board of Directors at American Chamber of Commerce in Germany
Munich, Germany
About
Thomas Werner was born in 1956 and is a German citizen. He has almost 30 years of experience in the pharmaceutical industry, most recently as Senior Vice President of GlaxoSmithKline where he was Managing Director for Germany and also coordinated the European oncology business. Prior to that, he was responsible for Glaxo Wellcome Germany and Central Europe, Bristol-Myers Squibb Germany and Convatec Germany/Central Europe. Werner sits on the boards of SkyePharma plc, BSN Medical and New Oncology AG. He is chairman of the investor advisory committee of Seventure Partners Health for Life capital investment fund and member of the advisory board of Riemser Pharma GmbH. Beside his business responsibilities he served for many years on the board of trustees of the Paul Ehrlich Foundation and also on the board of trustees of the Robert Koch foundation as well as on the Board of the German Verband der forschenden Arzneimittelunternehmen (vfa). He also served as a Director of the American C
Position in the VCSift Database
- • 13 investors hold the Member of Board of Directors role in VCSift. Thomas Werner is one of them.
- • 845 investors are based in Munich, Bayern, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Munich, Germany
Contact Information
Find more investors like Thomas
Search Investors